Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Physical activity improves quality of life for patients with pancreatic cancer

Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA
Physical activity improves quality of life for patients with pancreatic cancer ( Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA )
8 Jul 2022

Breast cancer and survivorship

Dr. Ashwin Mehta - Memorial Healthcare System, Florida, USA
Breast cancer and survivorship ( Dr. Ashwin Mehta - Memorial Healthcare System, Florida, USA )
8 Jul 2022

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer

Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer ( Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey )
30 Jun 2022

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

Dr Elad Neeman - Kaiser Permanente San Francisco Medical Center, San Francisco, USA
Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes ( Dr Elad Neeman - Kaiser Permanente San Francisco Medical Center, San Francisco, USA )
21 Jun 2022

War in Ukraine: Global cancer aid to support refugees

Dr Horia Vulpe , Dr Ruslan Baltaga
War in Ukraine: Global cancer aid to support refugees ( Dr Horia Vulpe , Dr Ruslan Baltaga )
21 Jun 2022

Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients

Dr Paul Richardson - Dana Farber Cancer Institute, Boston, USA
Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients ( Dr Paul Richardson - Dana Farber Cancer Institute, Boston, USA )
14 Jun 2022

Quizartinib advances overall survival in acute myeloid leukaemia patients

Dr Harry Erba - The Duke Cancer Institute, North Carolina, USA
Quizartinib advances overall survival in acute myeloid leukaemia patients ( Dr Harry Erba - The Duke Cancer Institute, North Carolina, USA )
13 Jun 2022

Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy show a superior MRD negativity rate for newly diagnosed MM patients

Dr Elias Mai - University Hospital Heidelberg, Heidelberg, Germany
Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy show a superior MRD negativity rate for newly diagnosed MM patients ( Dr Elias Mai - University Hospital Heidelberg, Heidelberg, Germany )
13 Jun 2022

Can we afford the cost of newly approved targeted therapeutics in the management of breast cancer globally?

Dr Sana Al Sukhun - Al Hyatt Oncology Practice, Amman
Can we afford the cost of newly approved targeted therapeutics in the management of breast cancer globally? ( Dr Sana Al Sukhun - Al Hyatt Oncology Practice, Amman )
6 Jun 2022

Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer

Dr Etienne Brain - Institut Curie, Paris, France
Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer ( Dr Etienne Brain - Institut Curie, Paris, France )
6 Jun 2022

COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity in inoperable locally advanced/metastatic urothelial carcinoma

Dr Sumanta K. Pal - City of Hope Comprehensive Cancer Center, Duarte, USA
COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity in inoperable locally advanced/metastatic urothelial carcinoma ( Dr Sumanta K. Pal - City of Hope Comprehensive Cancer Center, Duarte, USA )
5 Jun 2022

Safety follow-up of the randomized, phase 3 study DESTINY-Breast03

Dr Erika Hamilton - Sarah Cannon Research Institute, Tennessee, USA
Safety follow-up of the randomized, phase 3 study DESTINY-Breast03 ( Dr Erika Hamilton - Sarah Cannon Research Institute, Tennessee, USA )
5 Jun 2022